0RQJ.LSE Saniona AB

Healthcare Commercial Services & Supplies London Exchange
10.62 SEK
Close of Sep 2, 2026
8.66 28.15
Market cap
SEK 243M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is 0RQJ.LSE undervalued?

Graham number

The Graham number of Saniona AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Saniona AB fundamental analysis

No fundamental analysis for Saniona AB yet.

Saniona AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Saniona AB

Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom. It also develops medicines modulating ion channels. The company's product includes Tesofensine, a monoamine reuptake inhibitor that has completed Phase 3 clinical trial to treat people with obesity; and Tesomet, an oral investi…

Full company profile